Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![biospace Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::21793154.png) BioSpace [@biospace](/creator/twitter/biospace) on x 25.1K followers
Created: 2025-07-22 17:08:59 UTC

BMO Capital Markets pointed to FDA leadership, and CBER Director Vinay Prasad in particular, as potential factors in the agency’s decision to issue a complete response letter for Replimmune’s viral treatment RP1 for advanced melanomas. Shares of the company tumbled XX% on Tuesday.

#FDA #CBER #biospace



XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947705446082531613/c:line.svg)

**Related Topics**
[stocks](/topic/stocks)
[mergers and acquisitions](/topic/mergers-and-acquisitions)

[Post Link](https://x.com/biospace/status/1947705446082531613)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

biospace Avatar BioSpace @biospace on x 25.1K followers Created: 2025-07-22 17:08:59 UTC

BMO Capital Markets pointed to FDA leadership, and CBER Director Vinay Prasad in particular, as potential factors in the agency’s decision to issue a complete response letter for Replimmune’s viral treatment RP1 for advanced melanomas. Shares of the company tumbled XX% on Tuesday.

#FDA #CBER #biospace

XXX engagements

Engagements Line Chart

Related Topics stocks mergers and acquisitions

Post Link

post/tweet::1947705446082531613
/post/tweet::1947705446082531613